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Original Article
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Physiotherapy and Orthopaedic Surgery, Copenhagen University Hospital, Denmark
Abstract. [Purpose] To examine if length of stay was reduced following an early mobilisation programme in pa-
tients with community-acquired pneumonia, and secondary, if such a program influenced short-term rehospitalisation 
and mortality rates. [Participants and Methods] Ninety seven consecutive patients (51% men; over all mean ± SD age 
71.9 ± 16.5 years) with community-acquired pneumonia were included in the intervention group, and compared with 
a historical control group of 97 patients, matching at case level. Early mobilisation was defined as more than 20 min-
utes out of bed within 24 hours of hospitalisation. [Results] Eighty out of 97 patients in the intervention group were 
mobilised within 24 hours and length of stay for all patients was reduced with an average of 1.5 (95%CI: −0.2; 3.2) 
days compared to the control group. There was no significant difference between the two groups according to 30-day 
rehospitalisation and mortality. [Conclusion] An early mobilisation program seem to reduce the length of stay for 
patients with community-acquired pneumonia, and without an increase in short-term mortality and re-hospitalisation 
rates.
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INTRODUCTION
Community-acquired pneumonia (CAP) remains a leading cause of mortality all over the world, and elderly people are 
particularly at risk1, 2). CAP is an acute infection of the pulmonary parenchyma associated with clinical features (coughs, 
fevers, sputum production, and pleuritic chest pain) and accompanied by the presence of an acute infiltrate demonstrated on 
a chest radiograph—with or without supporting microbiological data3).
The incidence of adults hospitalised with pneumonia has increased during the last few decades4, 5). Risk factors for 
pneumonia include age, male gender, a general decrease in functional level, and malnutrition6, 7). The rehospitalisation rate 
within 30 days of discharge for patients with CAP is high, as indicated in a Danish study with a rate of 12.3%8).
Several studies document the effects of early mobilisation (EM) of patients in the intensive care unit (ICU) and in surgery 
units, and seems as a safe and effective intervention that can have a significant impact on functional outcomes9–13). However, 
to our knowledge, only one study documents the effects of early mobilisation of patients with CAP14). This multicentre study 
J. Phys. Ther. Sci. 30: 926–932, 2018
*Corresponding author. Dorte Melgaard (E-mail: dmk@rn.dk)
©2018 The Society of Physical Therapy Science. Published by IPEC Inc.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 
(by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
 The Journal of Physical Therapy Science
927
included 458 patients with CAP, and randomised to EM or usual care in different settings, and with a reduced length of stay 
(LOS), by an average of 1.1 days in the EM group compared to the usual care group14).
The primary aim of this study was therefore to evaluate if a similar EM programme of patients with CAP, when instigated 
in another setting would lead to a similar reduction in LOS. The secondary aim was to evaluate mortality during hospitalisa-
tion in addition to mortality and rehospitalisation within 30 days post-discharge.
The hypothesis was that patients hospitalised for CAP, mobilised within the first 24 hours, and following a progressive 
mobilisation programme during hospitalisation, could be discharged earlier, and without increased mortality and pulmonary 
related rehospitalisation rates.
PARTICIPANTS AND METHODS
Patients hospitalised with CAP at North Denmark Regional Hospital, a 385-bed public hospital, were consecutively 
included over the period from September 1, 2012 to February 28, 2013. Inclusion criteria for the early mobilisation group 
(EMG) were age ≥18 years old, CAP and admission to the Department of Lung Medicine. Patients receiving palliative 
treatment, diagnosed with dementia, transferred from another department or hospital, transferred to another department, or 
hospitalised from Friday afternoon to Sunday noon, were excluded.
A historical control group (CG) was matched with the EMG at case level according to gender, age (± 2 years), hospitalisa-
tion due to CAP in the same ward, and being discharged from this ward in the period from September 1, 2011 to February 
28, 2012. The exclusion criteria were the same and there was no change in medical guidelines for the two groups. The study 
was registered with the Danish Data Protection Authority (2008-58-0028). All patients were informed of the project; written 
informed consent was not requested according to the local Ethics Committee.
Demographic data on age, gender, admission date, discharge date, first acute rehospitalisation and mortality within 30 
days after discharge were recorded from the National Patient Register. Medical information was recorded from the electroni-
cal patient record, namely CRP, temperature, urea, respiratory rate, confusion, blood pressure at time of hospitalisation, time 
from admittance to initiation of antibiotic therapy, use of corticosteroids, medication by discharge, and comorbidity15).
The severity of pneumonia was assessed with the CURB6516, 17), which consists of five factors: confusion, urea, respiratory 
rate, blood pressure, and age >65 years. Each factor scores 1 point, up to a maximum score of 5 points. The CURB65 predicts 
mortality at 30 days, and mortality increases as the score increases in patients with CAP16). Comorbidity was assessed with 
the Charlson Comorbidity Index18, 19). Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of mortality 
associated with each. Scores are summed to a score between 0–31 to provide a total score predicting mortality. The higher the 
score, the higher the risk of mortality. For the EMG, the objectively assessed Cumulated Ambulation Score (CAS)20), the pre-
hospital New Mobility Score (NMS)21). The CAS describes the patients’ independence in three activities: 1) getting in and 
out of bed; 2) sitting down and standing up from a chair with arms; and 3) being able to walk with or without an appropriate 
walking aid. The score for each activity is cumulated to provide a daily score between 0 and 6, with 6 points indicating basic 
mobility independency20). The NMS was used to describe the patients’ pre-hospital functional level, assessed as the patient 
reported indoor, outdoor, and during shopping walking ability one week before hospitalisation. Each activity is scored from 
0–3 and cumulated to a score between 0 and 9, with high scores indicating a high level of function22). Three experienced 
physiotherapists, who received training in using the tests, mobilised the patients within 24 hours of hospitalisation, if at all 
possible. EM was defined as movement out of bed with a change from the horizontal to the upright position for at least 20 
minutes, and progressed during the entire hospital stay. The level of mobilisation at each session was individual and adjusted 
to the patients’ functional level and motivation. Physiotherapy was offered daily on weekdays. Patients in the control group 
were mobilised by physiotherapists or nurses, but all patients were not mobilised and those who were mobilised were not 
systematically mobilised within 24 hours from admission.
Patients were discharged after they had received antibiotics orally, were considered clinically stable, and were indepen-
dently mobile as recommended by the Danish Society of Respiratory Medicine23). Rehospitalisation was defined as admis-
sion within 30 days of discharge as a result of pneumonia or any other somatic disease, in the Northern Region of Denmark.
Descriptive statistics included the number and percentage of patients for categorical variables, and mean (± standard 
deviation) for continuous variables. Differences between the two study groups were analysed using Fisher’s exact test for 
categorical variables, and the two-sample t-test for continuous variables. Even though the distributions of some clinical 
variables were positively skewed, the number of observations per group was sufficiently large to justify using the t-test 
without a log transformation. The Kaplan-Meier method was applied to estimate the mean LOS with discharge as the event, 
and censoring for mortality. Z-tests were conducted to test for differences in the LOS between the two groups. Log rank tests 
were applied to test for differences in survival and rehospitalisation between the two groups. Throughout the analyses, 95% 
confidence intervals (CI) were reported and a p-value<0.05 was considered statistically significant. Statistical analyses were 
performed using Stata Version 13.1 software (Stata Corporation, College Station, TX, USA).
RESULTS
We enrolled 111 consecutive patients in the EMG of which 14 patients (71.4% male, mean age 77.6) were excluded due 
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to transfer to another department for further rehabilitation or to the ICU. The patients in the EMG and the CG were similar in 
age, gender, severity of pneumonia (CURB65), Charlson Comorbidity Index, time from admittance to initiation of antibiotic 
therapy and use of corticosteroids, while fewer patients in the EMG suffered from COPD (Table 1). Eighty out of 97 patients 
in the intervention group were mobilised within 24 hours. There are missing CURB65 data for 14 patients in the IG versus 
13 patients in the CG; this is primarily due to the missing registration of blood urea nitrogen.
Patients in the EMG were discharged after an estimated mean of 5.0 days (CI: 4.13; 5.85) compared to 6.5 days (CI: 5.1; 
7.9) for the CG, length of stay for all patients was reduced with an average of 1.5 (95%CI: −3.2; 0.2) days compared to the 
control group. A Z-test for the difference between the EMG and CG yielded a p value of 0.077.
From winter 2011/2012 to winter 2012/2013, the mean LOS for all patients in the department decreased from an average 
of 4.75 days to 4.68 days. This difference is not considered important and therefore, it has been disregarded.
In the EMG, patients with a CURB65 score of 0–2 had a shorter LOS compared to patients in the CG, and significant 
(p=0.04) for patients with a CURB65 score of 2 (p=0.041) (Table 2). At the same time, patients in the EMG with COPD 
stayed an average of 2.1 days shorter (p=0.028) in hospital than those in the CG with COPD (Table 2).
In the EMG, four patients (4.1%) died during hospitalisation, compared to seven patients (7.2%) in the CG (p=0.351) 
(Table 3). Four out of 93 patients (4.3%) in the EMG versus 3 out of 90 patients (3.3%) in the CG died within the 30-day 
post-discharge follow-up period (p=0.738).
In the EMG, 19 out of 93 (20.4%) patients were re-hospitalised within 30 days post-discharge compared to 13 out of 90 
(14.4%) in the CG (p=0.274), as illustrated in Table 4. However, five of the patients in the EMG were re-hospitalised due 
to diseases other than lung-related disorders e.g. aortic stenosis and cancer, as compared to one patient in the CG who was 
re-hospitalised due to pancreatitis.








Mean 95 % CI
0 15 3.6 2.2; 4.9 14 (93.3%) 16 4.3 3.2; 5.5 −0.8 −2.6; 1.0 0.381
1 29 5.4 3.9; 6.9 25 (82.2%) 26 7.1 3.6; 10.6 −1.7 −5.5; 2.1 0.379
2 26 5.0 4.0; 6.1 22 (84.6%) 30 8.1 5.3; 10.9 −3.1 −6.1; 0.1 0.041
3* 13 8.9 5.4; 12.4 9 (69.2%) 10 7.1* 4.7; 9.5 1.7 −2,5; 6.0 0.419
Missing 14 1.8 −2.42; 0.40 10 (71.4%) 15 2.8 −2.47; 0.45 1.0 0.155
COPD 39 4.3 3.5; 5.1 33 (84.6%) 54 6.4 4.7; 8.0 −2.1 −3.9; −0.2 0.028
*Two patients with respectively CURB65 of 4 and 5 points included.
Table 1.  Characteristics of patients
Early mobilisation group 
(N=97)
Control group  
(N=97) p-value
Age (years), mean ± SD 71.9 ± 16.5 71.9 ± 16.5 0.982
Gender
Male 51 (52.6) 51 (52.6) 1.000
New Mobility Score, mean ± SD 6.6 ± 3.2
CURB65 scores
0 15 (18.1) 16 (19.1)
1 29 (34.9) 26 (31.0)
2 26 (31.3) 30 (35.7)
3 13 (15.7) 10 (11.9)
4 0 (0) 1 (1.2)
5 0 (0) 1 (1.2)
Missing 14 (14.4) 13 (13.4) 0.839
Time to antibiotic 9.97 (± 6.50) 10.02 (±7.69) 0.963
Time to corticosteroids 53 (54.64) 48 (49.48) 0.566
Charlson Comorbidity Index 4.6 ± 2.0 4.5 ± 1.8 0.910
COPD 39 (40.2) 54 (55.7)
Data are numbers (%), otherwise as stated.
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<70 years 0 (0) 36 (38.7) 2 (28.6) 33 (36.7)
≥70 years 4 (100) 57 (61.3) 5 (71.4) 57 (61.3)
Gender 
Male 2 (50) 49 (52.7) 4 (57.1) 47 (52.2)
New mobility score
NMS 0–8 4 (100) 38 (41.3)
NMS 9 0 (0) 54 (58.7)
CURB65
0 0 (0) 15 (18.8) 0 (0) 16 (20.3)
1 0 (0) 29 (36.3) 1 (20.0) 25 (31.7)
2 1 (33.3) 25 (31.3) 2 (40.0) 28 (35.4)
3* 2 (66.7) 11 (13.8) 2 (40.0) 10 (12.7)
Charlson comorbidity index 5.5 ± 1 4.5 ± 2.0 5.4 ± 1.0 4.4 ± 1.9
30 days after discharge n=4 (4.3) n=89 (95.7) n=3 (3.3) n= 87 (96.7)
Age
<70 years 0 (0) 36 (40.5) 1 (33.3) 32 (36.8)
≥70 years 4 (100) 53 (59.6) 2 (66.7) 55 (63.2)
Gender
Male 1 (25) 48 (53.9) 2 (66.7) 45 (51.7)
New mobility score
NMS 0–8 3 (75.0) 35 (39.8)
NMS 9 1 (25.0) 53 (60.2)
CURB65
0 0 15 (19.5) 0 16 (21.1)
1 2 (66.7) 27 (35.1) 1 (33.3) 24 (31.6)
2 0 25 (32.5) 2 (66.7) 26 (34.2)
3* 1 (33.3) 10 (13.0) 0 10 (13.2)
Charlson comorbidity index 6.5 ± 3.7 4.4 ± 1.9 4 ± 1.7 4.5 ± 1.9
Data are reported as numbers (%), otherwise as stated.
*Two patients with respectively CURB65 of 4 and 5 points included.
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DISCUSSION
The present study shows a clear tendency towards a shorter LOS following an early systematic, progressive physiothera-
peutic mobilisation programme, compared to a usual care group of patients with CAP.
Several studies document that EM of patients in ICU lead to significant decreases in LOS9, 10, 24–26), but the evidence for 
EM of patients with CAP is still limited Thus, as previously mentioned, there is only one RCT conducted in the US that 
reported a reduced LOS of 1.1 days for patients with CAP following an EM programme14). Our finding of an average 1.5-day 
reduction is in accordance with this and adds to the currently sparse knowledge of the positive effects of early mobilisation 
on the LOS for patients with CAP and without an increase in short-term re-hospitalisation and mortality.
We also found an association between the CURB65 score and the LOS for both the EMG and CG group. Interestingly, 
patients with a CURB65 score of 2 seem to benefit the most from the EM program, as indicated with an average reduction in 
the LOS of 2.7 days compared to the CG. This finding appears to correspond to those with a Pneumonia Severity Index score 
of 3 for patients in the EM group in the study by Mundy et al14). However, this comparison should be interpreted with caution 
due to the different score systems used.
The in-hospital mortality rate of 4.1% in the EMG versus 7.2% in the CG in the present study is low compared to that 
reported from a Danish register study showing an in-hospital mortality rate of 11.5%8). The corresponding 30-day post-
discharge mortality rate was 16.2% in the Danish register study, compared to 4.3% in the EMG and 3.3% in the CG, in the 
present study. The lower mortality rates in the present study can possible be explained by the fact that patients with very 
severe CAP are included neither in the present study nor in the study by Mundy et al.14), due to transfer to the ICU. The 
mortality during hospitalisation in the study by Mundy et al.14) was lower in the IG than in the CG, but as in the present study, 
no significant difference was seen for mortality during hospitalisation nor was there any difference 30 days post-discharge.
The post-discharge rehospitalisation rates of 20.4% in the EMG and 14.4% in the CG in the present study is higher than that of 
the abovementioned Danish register study where it was 12.3%8). A lover functional level before admission appears to be the most 
important risk factor for rehospitalisation in the EMG. The frequency of rehospitalisation was higher in the EMG even though it 
was not significant, and the difference was primarily due to patients being rehospitalised due to diseases unrelated to the lungs.
The strength of this study is that it consecutively included a representative sample of patients hospitalised with CAP. 
Another strength is that the two groups were matched at case level, according to age and gender but also to time to antibiotic 
therapy and the use of corticosteroids that can influence the LOS significantly27–32).




p valueRehospitalised  
n=19 (20.4)




Not rehospitalised  
n=77 (85.6)
Age
<70 years 6 (31.6) 30 (40.5) 6 (46.2) 27 (35.1)
≥70 years 13 (68.4) 44 (59.5) 0.600 7 (53.9) 50 (64.9) 0.537
Gender
Male 9 (47.4) 40 (54.1) 0.618 10 (76.9) 37 (48.1) 0.073
New Mobility Score
NMS 0–8 12 (66.7) 26 (35.1) 0.018
NMS 9 6 (33.3) 48 (64.9)
CURB65
0 3 (15.8) 12 (19.7) 4 (30.8) 12 (18.2)
1 8 (42.1) 21 (34.4) 2 (15.4) 23 (34.9)
2 6 (31.6) 19 (31.2) 5 (38.5) 23 (34.9)
3* 2 (10.5) 9 (14.8) 0.964 2 (15.4) 8 (12.1) 0.482
Missing 3 (21.4) 11 (78.6) 2 (15.4) 11 (84.6)
CCI (mean) 4.5 (3.6; 5.4) 4.5 (4.0; 5.0) 0.939 4.5 (3.4; 5.7) 4.4 (4.0; 4.9) 0.885
COPD 10 (52.6) 28 (37.8) 0.299 7 (53.9) 41 (53.3) 1.000
LOS (days) 5.6 (3.8; 7.4) 4.4 (3.6; 5.2) 0.247 6.7 (4.3; 9.1) 5.8 (4.4; 7.3) 0.529
Cause for rehospitalisation
Pneumonia, COPD 14 (73.7) 12 (92.3)
Other diseases 5 (26.3) 1 (7.7)
Data are reported as numbers (%), otherwise as stated.
*Two patients with respectively CURB65 of 4 and 5 points included.
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Weaknesses are the non-randomised design with a historical CG, that data of the pre-admittance functional level was not 
available in the CG, and that fewer patients by coincidence suffered from COPD in the EMG. Still, patients with COPD in the 
EMG had shorter LOS as compared to those in the CG. Another limitation was that CURB65 scores were missing for some 
patients, but similarly in both groups and with similar outcomes. Planning the study, we considered a randomised controlled 
design, but there are additional challenges to performing such a trial33). Thus, treating patients hospitalised for the same 
reason but randomised into different treatment programs in the same unit or even in the same room is difficult and with some 
ethical problems. Thus, even though the patients were mobilised by physiotherapists in the EMG, the nurses also started to 
focus on EM in the present study, even though they were not asked to mobilise the patients more than usual. A multi-centre 
study might be a possibility, but different departments are organised in different ways, and it would be difficult to standardise 
the treatment completely. Another weakness is the low number of participants. However, despite the associated lack of power, 
we did find a similar reduction of LOS as in the larger study of Mundy et al14).
In summary, an EM programme compared to usual care appears to reduce the LOS for patients with CAP. Patients with 
CAP and a CURB65 score of 2 or with COPD seem to gain the most of the EM programme compared to patients who fol-
lowed the usual care programme. Thus, we suggest that the present study, in addition to the positive findings of the previous 
RCT, leads to a well-powered multicentre RCT for developing more secure evidence for EM for patients with CAP.
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